2024 Speakers

Aarush Pandurang

Aarush Pandurang

Moderator | INDEX Holdings - UAE**

Moderator

Ava Kwong

Ava Kwong

Clinical Professor, Chief of Division of Breast Surgery | The University of Hong Kong

Professor Ava Kwong is Daniel C K Yu Professor in Breast Cancer Research and Clinical Professor of the Department of Surgery at The University of Hong Kong (HKU), Chief of Division of Breast Surgery at HKU, Queen Mary, Tung Wah and HKU-Shenzhen Hospital. Professor Kwong’s research interests focus on breast and ovarian cancer genetics, advanced surgical technologies and clinical trials in oncological treatment. She has authored chapters in textbooks and has over 280 peer-reviewed publications in reputable journals. She has received numerous grants and awards, including a commissioned grant from The Government of the Hong Kong Special Administrative Region (HKSAR) to study the risk factors of breast cancer and this cooperated study has led to the establishment of the first subsidized risk based breast screening “Breast Cancer Screening Pilot Programme” in Hong Kong. In 2019, She was received Uccio Querci della Rovere Award of BASO~ The Association for Cancer Surgery in United Kingdom. In 2023, she was awarded the HKU Faculty Clinical Service Excellence Awards. Beyond her research, Professor Kwong is active in public and community services. She is the Founder and Chairperson of the Hong Kong Hereditary Breast Cancer Family Registry, a charitable organization. She is also a member of several committees including Cancer Coordinating Committee of the Health Bureau, The Government of HKSAR and Central Committee on Cancer Service of Hospital Authority, Hong Kong.

Elaine Lim

Elaine Lim

Senior Consultant, Division of Medical Oncology | National Cancer Centre Singapore

Dr Elaine Lim is Senior Consultant, Division of Medical Oncology, National Cancer Centre of Singapore (NCCS); Director, Division of Community Outreach & Philanthropy, NCCS; President, Singapore Society of Oncology; Senior Clinician Scientist, Genome Institute of Singapore; Clinician Researcher, Institute of Molecular & Cell Biology, Singapore. She has continued her laboratory research activities in collaboration with the Genome Institute of Singapore and the Institute of Molecular and Cell Biology, and actively participates in clinical trials. She founded Breast Cancer Research Singapore, a consortium of clinicians and scientists dedicated to basic and translational breast cancer research in Singapore, whose Patron is the President of Singapore, Her Excellency Halimah Yacob. Dr. Lim spearheaded NCCS Home Care, and has contributed to national healthcare financing and policy workgroups set up under the auspices of the Ministry of Health, Singapore.

Faye Lim

Faye Lim

Senior Consultant Radiation Oncologist | National Cancer Centre

Dr Faye Lim is a Senior Radiation Oncologist at the National Cancer Centre Singapore who specializes in both Breast and Gastrointestinal Cancers. She trained at the Mount Vernon Cancer Centre and the University College London Hospitals in the United Kingdom. She has a special interest in the use and optimization of proton therapy and is the Clinical Lead for proton therapy in the treatment of breast cancer.

Frances Que

Frances Que

Medical Oncologist | St Luke’s Medical Center

Dr Frances Victoria Que completed her internal medicine residency and medical oncology fellowship training at St Luke’s Medical Center, Quezon City, Philippines, an observership in cancer genetics at the National University Hospital Singapore, and cancer genomic medicine fellowship training at the National Cancer Center Singapore. She is currently an active consultant for internal medicine, medical oncology, and cancer genetics and genomics at St Luke’s Medical Center Quezon City and Global City, and Makati Medical Center, Philippines.

Hee Jeong Kim

Hee Jeong Kim

Breast Cancer Specialist | Asan Medical Center

A Ph.D. and M.S. graduate of Ulsan University, Prof. Kim Hee Jeong completed her M.D. from Cheon Buk National University. She is currently a Professor at University of Ulsan and previously was a Visiting Doctor at Dana Farber Harvard Medical School (2017-2019) and Dana Farber Cancer Institute, Memorial Sloan Kettering Cancer Center (2010). She has published the Journal of Clinical Oncology in "Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor–Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial" and published 162 SCI and SCIE papers.

Joline Lim

Joline Lim

Consultant, Department of Haematology-Oncology | National University Cancer Institute

Dr Joline Lim is a consultant and clinician scientist at the National University Cancer Institute, Singapore. Her primary clinical and research interests are in breast oncology and early phase clinical trials, with a special focus on the development of novel anti-cancer therapeutic agents and biomarkers. Dr Lim has a keen interest in translational research involving novel anti-tumour therapies including molecular targeted agents and immunotherapies, and the application of emerging predictive and pharmacodynamic biomarkers.

Kiley Loh

Kiley Loh

Medical Oncologist | Penang Adventist Hospital

Dr Kiley Loh is a medical oncologist specializing in treating breast cancers, managing side effects and cancer survivorship. Dr Loh joined Curie Oncology to lead its services in Malaysia at the Penang Adventist Hospital. He continues to subspecialize in breast cancers and remains a visiting consultant with NCCS’ Division of Supportive and Palliative to continue his work in cancer supportive and survivorship care.

Lim Sue Zann

Lim Sue Zann

Consultant in Surgical Oncology | SingHealth Duke-NUS Breast Centre

Dr Lim Sue Zann is a consultant in the Singhealth Duke-NUS Breast Centre. She graduated with honours from the Faculty of Medicine, University of Malaya in 2008. She became a Fellow of the Royal College of Surgeons (Edinburgh) and registered as a specialist in general surgery in 2017. She has also completed the Advanced Breast Surgery Fellowship Programme under Singhealth Duke-NUS Breast Centre and Department of Reconstructive and Aesthetic Surgery, Singapore General Hospital. This fellowship focuses on both oncological and reconstructive breast surgery. In 2022, she underwent surgical training in Asan Medical Center in South Korea focusing on minimally invasive breast surgery. In 2023, she also visited the Royal Marsden Hospital in London to learn new techniques on oncoplastic breast surgery. She is also actively involved in medical education. She received the Dean’s Award for Teaching Excellence from Yong Loo Lin Medical School in 2013. She is also an adjunct assistant professor in DUKE-NUS Medical School. She was appointed as a Physician Faculty Member for SingHealth General Surgery Residency Program in 2018 and now a Core Faculty Member in this programme. She is also the Clinical Core Faculty Member for Post Graduate Year 1 Doctors in the Department of General Surgery Singapore General Hospital. Her research interests are mainly in de-escalation of axillary treatment in breast cancer patient, breast sarcoma and phyllodes tumours. Based on her work in the above topic, she was awarded the Singapore General Hospital Research Grant in 2016.

Ma Jun

Ma Jun

Medical Oncologist | Singapore General Hospital

Dr Ma Jun received her undergraduate degree from Monash University, Australia. She trained in Medical Oncology in National Cancer Centre Singapore and is currently specialising in breast cancer treatment. She has a special interest in young women with breast cancer as well as supportive care needs in breast cancer.

Mastura Md Yusof

Mastura Md Yusof

Cancer Centre Head and Consultant Clinical Oncologist | Pantai Hospital Kuala Lumpur

Dr. Mastura Md. Yusof is a Consultant Clinical Oncologist and Head of the Cancer Centre at PICASO Hospital and Pantai Hospital Kuala Lumpur, She leads the research unit at Pantai Hospital Kuala Lumpur, overseeing numerous clinical trials in breast and lung cancer including fundamental trials that resulted in the approval of pembrolizumab in metastatic triple negative breast cancer. She is actively participating in international clinical trials in varied innovative therapies such as targeted therapies, PARP inhibitors, immunotherapies and antibody-drug conjugates and has co-authored numerous peer-reviewed publications in national and international journals.

Matteo Lambertini

Matteo Lambertini

Associate Professor and Consultant in Medical Oncology | IRCCS Policlinico San Martino Hospital – University of Genova

Dr. Matteo Lambertini is an associate professor and consultant in medical oncology at the IRCCS Policlinico San Martino Hospital – University of Genova in Genova (Italy). He is mainly focused in the care of breast cancer patients and is deeply involved in breast cancer research. Thanks to the support of the European Society for Medical Oncology (ESMO), he has recently completed his PhD at the Universite Libre de Bruxelles (U.L.B.) in Brussels (Belgium) with a project entitled “Unmet Fertility and Pregnancy-related Issues in Young Breast Cancer Patients". He is a member of the guideline group on fertility preservation in cancer patients for the European Society for Medical Oncology (ESMO), the European Society of Human Reproduction and Embriology (ESHRE) and the Italian Association of Medical Oncology (AIOM).

Muhammad Azrif

Muhammad Azrif

Consultant Clinical Oncologist | Prince Court Medical Centre

Dr. Muhammad Azrif graduated from the Royal Free Hospital & University College London School of Medicine, London, UK in 1997. After completing his training in internal medicine and obtaining his MRCP (UK) in 2000, he entered the specialist training program in Clinical Oncology at the Christie Hospital, Manchester, UK. He became a Fellow of the Royal College of Radiologists (Clinical Oncology) in 2005 and attained his Certificate of Completion of Specialist Training (UK) before admission to the UK General Medical Council Specialist Register in 2006. He was awarded a one-year Clinical Research Fellowship to the Department of Radiation Oncology, University of Toronto, Canada in mid-2006. He returned to Malaysia in 2007 and served at the National University of Malaysia Medical Centre (UKMMC) as a Consultant Clinical Oncologist for 5 years before joining private practice in 2012. He has served on various national oncology committees, published in peer-reviewed journals as well as participated in numerous clinical trials, cancer advisory boards, and expert panels.

Nur Diana Ishak

Nur Diana Ishak

Genetic Counsellor | National Cancer Centre

Diana is a genetic counsellor with the Cancer Genetics Service at the National Cancer Centre Singapore. Beyond her clinical role, Diana is passionate about public education and outreach, actively engaging with support groups and fostering greater patient awareness and support across diverse communities.

Sabrina Ngaserin

Sabrina Ngaserin

Head of Breast Surgery | Sengkang General Hospital, SingHealth Duke-NUS Breast Centre, Singapore

Assistant Professor Sabrina Ngaserin is Head of Breast Surgery at Sengkang General Hospital (SKH), SingHealth Duke-NUS Breast Centre, Assistant Professor of Duke-NUS Post-graduate Medical School and Yong Loo Lin School of Medicine, National University of Singapore, Physician Faculty with SingHealth’s General Surgery Residency Program, and Programme Director of the SKH Advanced Breast Surgery (Oncoplastic and Minimally Invasive) Fellowship programme. Formally trained in oncoplastic breast surgery, minimally invasive and endoscopic breast surgery, her main interest lies in cutting edge breast cancer surgical techniques that considers the patients oncological safety alongside their need for aesthetic, quality of life and function preserving solutions

Samuel Ow

Samuel Ow

Senior Consultant Medical Oncologist | National University Cancer Institute

Dr. Samuel Ow is Senior Consultant Medical Oncologist and Clinical Director at the Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS). His clinical and research interests are in Breast Cancer and Clinical Cancer Genetics. He sits on the committee for the Breast Cancer Awareness Campaign at the institutional and national level, to help drive greater awareness for breast cancer screening and prevention in the general public.

Sara Tolaney

Sara Tolaney

Chief, Division of Breast Oncology / Associate Professor of Medicine | Dana-Farber Cancer Institute / Harvard Medical School

Dr. Tolaney received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Her research focuses on the development of novel therapies in the treatment of breast cancer.

Stephen Johnston

Stephen Johnston

Professor of Breast Cancer Medicine and Consultant Medical Oncologist | The Royal Marsden NHS Foundation Trust

Stephen Johnston is a Professor of Breast Cancer Medicine and Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. He is currently a Clinical Director of the Breast, Lung and AOS Clinical Business Unit at The Royal Marsden. He has published over 250 breast cancer related articles in peer-reviewed journals, and is a regular invited lecturer at national and international meetings.

Thitiya Sirisinha Dejthevaporn

Thitiya Sirisinha Dejthevaporn

Assistant Professor, Division of Medical Oncology | Ramathibodi Hospital, Mahidol University, Bangkok

Dr Thitiya Dejthevaporn is Assistant Professor at the Medical Oncology Unit, Department of Internal Medicine, Ramathibodi Hospital, in Bangkok, Thailand. She obtained her Doctor of Medicine (First Degree Honor) from the Mahidol University in 1991, and completed both her residency in Internal Medicine and Fellowship training in Hematology and Medical Oncology at the University of Alabama, Birmingham, USA. Dr Dejthevaporn has special interest in breast cancer, GU cancer, brain tumor and palliative care. She has conducted clinical research in treatment of various malignancies including breast and lung cancer. She has also contributed to the development of National Practice Guidelines for breast, gastric and esophageal cancers with the National Health Security Office and National Cancer Institute. She is currently a vice president of the Thai Society of Clinical Oncology and Head of Medical Oncology Unit at Ramathibodi Hospital, Mahidol University.

Timothy Tay

Timothy Tay

Senior Consultant Pathologist | Singapore General Hospital

Dr. Timothy graduated from Yong Loo Lin School of Medicine, National University of Singapore and did his postgraduate residency training in Anatomical Pathology. Having completed his fellowship exams, he is a Fellow of both The Royal College of Pathologists (United Kingdom) as well as The Royal College of Pathologists of Australasia. He has a special interest in Breast, Bone and Soft Tissue and Molecular Pathology and was awarded the SingHealth Health Manpower Development Plan (HMDP) Fellowship to pursue further training at the Memorial Sloan Kettering Cancer Centre in New York, USA as well as Institute of Pathology, Heidelberg University Hospital, Germany. Timothy currently holds a Senior Consultant position at the Singapore General Hospital Department of Anatomical Pathology within which he also heads the Anatomical Molecular Laboratory (former Translational Pathology Centre).

Tira Tan

Tira Tan

Consultant Medical Oncologist | National Cancer Centre Singapore

Dr Tira Tan is a consultant medical oncologist at the National Cancer Centre Singapore with a clinical focus in the treatment of breast cancers and early phase drug development. Dr Tan chairs the pre-operative and young women’s breast cancer programs at NCCS and is the divisional deputy director of research as well as a primary and co-investigator on many early and late phase studies specifically in novel therapeutics and treatment strategies in triple negative breast cancer.

Tom Chen

Tom Chen

Attending Physician, Department of Oncology | National Taiwan University Hospital

Dr. Tom W. Chen is currently an attending physician at the Department of Oncology, National Taiwan University Hospital (NTUH) and National Taiwan University Cancer Center in Taipei, Taiwan. Dr. Chen received internal medicine training followed by a fellowship course as a medical oncologist in NTUH. Afterwards, he joined Drug Development Program (DDP) in Princess Margaret Cancer Centre in Toronto, Canada as a clinical fellow to study early phase clinical trials with Dr. Lillian Siu and Dr. Phil Bedard. During his stay in Princess Margaret, he gained more experience with next-generation sequencing and precision medicine, as well as interest in breast cancer patients. After returning to NTUH, he joined in NTUH breast cancer team and was invovled in various clinical trials including the bevacizumab, cisplatin, and etoposide (the BEEP) regimen in brain cancer patients with brain metastases, the ESR1 mutation landscape in Asian ER+/HER2- metastatic patients, and the combination of lapatinib and vinorelbine in HER2+ MBC.. His publications included studies regarding the thromboembolism events of tamoxifen in Asian population, HER2 treatment reviews, and next-generation sequecing studies in breast cancer. Besides breast cancer, he is also involved in sarcoma and phase I drug development studies.

Yang Liying

Yang Liying

Senior Consultant | Singhealth

Dr Yang Liying is a Consultant in the Department of Obstetrics & Gynaecology. She graduated from the Yong Loo Lin School of Medicine of the National University of Singapore with a Bachelor of Medicine and Bachelor of Surgery (MBBS) degree in 2008. She completed her Master of Medicine in Obstetrics & Gynaecology in 2013 and became a Member of the Royal College of Obstetrics & Gynaecology in the same year. She gained accreditation as a specialist in Obstetrics & Gynaecology in 2016 and obtained her Masters in Medical Genetics in 2021. She is also an International Board-Certified Lactation Consultant (IBCLC). Dr Yang brings an evidence-based and patient-centric approach to clinical care. Her sub-specialty interests are in Maternal-Fetal Medicine, Prenatal Genetics and Breastfeeding Medicine, as she believes that pregnancy is a unique opportunity to provide quality care that can influence the long-term health of the family, mother and child.

Yap Yoon Sim

Yap Yoon Sim

Senior Consultant | National Cancer Centre Singapore

Dr. Yap is Senior Consultant in the Division of Medical Oncology at the National Cancer Centre Singapore, and Associate Professor at Duke-National University Singapore. A recipient of the Singapore National Medical Research Council (NMRC) Clinician Scientist Award (CSA), her research focuses primarily on clinical and translational research in breast cancer, including liquid biopsies and predictive biomarkers, development of novel therapeutic strategies, and epidemiologic studies on treatment outcomes in breast cancer. She is the principal investigator of several phase 1 to 3 clinical trials for various compounds, including CDK inhibitors, PI3K and mTOR inhibitors, selective estrogen receptor degraders, HER2-targeting agents and immunotherapy, in addition to investigator-initiated studies.

Zhang Zewen

Zhang Zewen

Medical Oncologist | National Cancer Centre Singapore

Dr Zhang Zewen is a Medical Oncologist in NCCS sub-specializing in Breast cancer and Gynecological cancer. He has a special interest in Cancer Genetics, and is part of the Cancer Genetics Service team involved in research related to hereditary cancer predisposition syndromes, including Hereditary Breast and Ovarian Cancer and Lynch syndrome.